Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

DANIEL L. BURKHEAD, MD LTD

NPI: 1942253075 · LAS VEGAS, NV 89129 · Interventional Pain Medicine Physician · NPI assigned 05/18/2006

$94K
Total Medicaid Paid
21,901
Total Claims
19,683
Beneficiaries
21
Codes Billed
2018-06
First Month
2024-11
Last Month

Provider Details

Authorized OfficialBURKHEAD, DANIEL (OWNER)
NPI Enumeration Date05/18/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 1,369 $3K
2019 8,725 $19K
2020 4,423 $15K
2021 2,948 $21K
2022 1,320 $13K
2023 1,972 $12K
2024 1,144 $11K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3,809 3,429 $91K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 74 66 $2K
80305 264 238 $514.40
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 336 327 $204.46
1036F 1,598 1,447 $0.00
G9903 Patient screened for tobacco use and identified as a tobacco non-user 1,591 1,440 $0.00
G9907 Documentation of medical reason(s) for not providing tobacco cessation intervention on the date of the encounter or within the previous 12 months (e.g., limited life expectancy, other medical reason) 2,467 2,219 $0.00
G8420 Bmi is documented within normal parameters and no follow-up plan is required 35 29 $0.00
G9583 Patients prescribed opiates for longer than six weeks 1,198 1,085 $0.00
G9902 Patient screened for tobacco use and identified as a tobacco user 60 50 $0.00
G9970 Clinician who referred the patient to another clinician did not receive a report from the clinician to whom the patient was referred 44 38 $0.00
G8730 Pain assessment documented as positive using a standardized tool and a follow-up plan is documented 1,279 1,121 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 1,873 1,690 $0.00
G9561 Patients prescribed opiates for longer than six weeks 1,238 1,118 $0.00
G9584 Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy 1,583 1,410 $0.00
G9578 Documentation of signed opioid treatment agreement at least once during opioid therapy 1,591 1,418 $0.00
G9577 Patients prescribed opiates for longer than six weeks 1,215 1,101 $0.00
G9562 Patients who had a follow-up evaluation conducted at least every three months during opioid therapy 760 657 $0.00
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 784 708 $0.00
4004F 60 50 $0.00
4040F 42 42 $0.00